<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteStem Cell Engineering &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/stem-cell-engineering/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>A model of Collaborative Ethics to guide translational research from fundamental discoveries to real-world applications</title>
				<link>https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/</link>
        <pubDate>Tue, 25 Jun 2024 14:55:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Neurology]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40318</guid>
                            <description>Multi-stage process driven by close and continued collaboration between scientists and ethicists ensures that new breakthrough technologies are safe and beneficial for all</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; In sciences, disruptive research that is breaking new ground often raises new and not&#x2d;yet&#x2d;explored ethical questions. Although new scientific breakthroughs can have the power to change how we understand and live in the world, the ethical implications of technologies that will emerge based on these new insights can affect an emerging field&rsquo;s public acceptance and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/</link>
          <title>02/10/2017  BOSTON, MA    Bioethicist Jeantine Lunshof (cq) poses for a portrait at Harvard Medical School.   (Aram Boghosian for The Boston Globe)</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2019/07/23151323/Jeantine-Lunshof-headshot.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1d6fdc21b39cb23fd08089bf01d3ec21"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute’s CircaVent team awarded grant from BD2 to advance research into bipolar disorder and development of more effective drugs</title>
				<link>https://wyss.stage.a17.io/news/wyss-institutes-circavent-team-awarded-grant-from-bd2-to-advance-research-into-bipolar-disorder-and-development-of-more-effective-drugs/</link>
        <pubDate>Tue, 03 Oct 2023 14:56:09 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Neurology]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37749</guid>
                            <description>The philanthropic $4.5 million grant will enable the team to screen new, re-purposed drug candidates and apply them to patient-derived brain organoids to delve deeply into the causes of bipolar disorder</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (Boston) &mdash; The Wyss Institute&rsquo;s CircaVent project will be supported by Breakthrough Discoveries for thriving with Bipolar Disorder (BD2), which aims to advance scientific understanding of the causes underlying bipolar disorder (BD). The CircaVent project examines the molecular mechanisms of common bipolar interventions and the pathophysiology of bipolar disorder to&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/wyss-institutes-circavent-team-awarded-grant-from-bd2-to-advance-research-into-bipolar-disorder-and-development-of-more-effective-drugs/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/wyss-institutes-circavent-team-awarded-grant-from-bd2-to-advance-research-into-bipolar-disorder-and-development-of-more-effective-drugs/</link>
          <title>The BD<sup>2</sup> grant team. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/10/02124143/20230929-CircaVent-BD2-Grant-Team-90FCDB65-6961-4B24-9E97-AA0BBBE12FE1_1_201_a.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d486b3c235eb1b1381c9dc3c3142c8ce"/></url>
				</image>
        			</item>

		
			<item>
				<title>Adding immunity to human kidney-on-a-chip advances cancer drug testing</title>
				<link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
        <pubDate>Wed, 23 Aug 2023 14:57:37 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37512</guid>
                            <description>An immune-infiltrated human kidney organoid-on-chip model enables assessment of kidney toxicities to immunotherapeutic T cell bispecific antibody drugs with high resolution</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (Boston) &mdash; A growing repertoire of cell and molecule&#x2d;based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells. An emerging class of such immunotherapeutics, known as T cell bispecific antibodies (TCBs), are of growing importance with several TCBs that the U.S. Food and Drug Administration (FDA)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
          <title>The team’s study demonstrated in a novel immune-infiltrated human kidney organoid-on-chip model that a T cell bispecific antibody (TCB) targeting an antigen from the Wilms tumor-1 protein (WT1-TCB) specifically recruits immune cells, including cytotoxic T cells (shown in green), to clusters of podocytes (shown in blue), leading to their destruction. The grey staining is derived from dying cells. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/22163738/Kidney-organoid-on-chip.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d47559348b52211470cb82f9a9d11ed3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Aric Lu on Breaking Biology by Bioprinting Complex Tissue</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-aric-lu-on-breaking-biology-by-bioprinting-complex-tissue/</link>
        <pubDate>Thu, 18 May 2023 15:06:04 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=36823</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. Like each cell in the body, each paddler in a dragon boat plays a specific role. In both cases, each has different characteristics and strengths, but all must work together in tandem for the&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-aric-lu-on-breaking-biology-by-bioprinting-complex-tissue/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-aric-lu-on-breaking-biology-by-bioprinting-complex-tissue/</link>
          <title>Aric Lu, Ph.D. Student. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/05/16162028/HOW-Aric-Liu-0970.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=37f6e1a7e80b8b70f88d4ba28676b161"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagining Infertility – An Interview with Christian Kramme</title>
				<link>https://wyss.stage.a17.io/media-post/reimagining-infertility-an-interview-with-christian-kramme/</link>
        <pubDate>Tue, 28 Mar 2023 14:12:12 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Reproductive Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=36273</guid>
                                                <content:encoded><![CDATA[<p>Christian Kramme imagines a world where all people can have a child on their own time frame. Such &ldquo;reproductive autonomy&rdquo; is not the case today &ndash; infertility is a growing problem worldwide, and existing treatments like IVF are incredibly taxing on women&rsquo;s bodies and too expensive for most of the global population to access. Listen to our interview with Christian to learn how he is working to turn&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/reimagining-infertility-an-interview-with-christian-kramme/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/reimagining-infertility-an-interview-with-christian-kramme/</link>
          <title>Co-first author of the paper, Christian Kramme, at his bench at the Wyss Institute. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/09/23104321/STAMPScreen-Christian-Kramme-posed-1135.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3733c7491501107b63e8c96612448bd3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagining Infertility – An Interview with Christian Kramme</title>
				<link>https://wyss.stage.a17.io/news/reimagining-infertility-an-interview-with-christian-kramme/</link>
        <pubDate>Tue, 28 Mar 2023 14:11:15 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Reimagine the World]]></category>
		<category><![CDATA[Reproductive Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=36239</guid>
                            <description>Kramme is using technology developed at the Wyss Institute to enable people to have children on their own terms</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell Every day, members of the Wyss community reimagine a world where anything is possible. It&rsquo;s a world of scientific discovery, imagination, and innovation, where diseases are cured, climate change is reversed, pandemics are prevented, and lives are changed for the better. The ideas that we are bringing to life through our research and engineering might seem like science fiction&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/reimagining-infertility-an-interview-with-christian-kramme/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/reimagining-infertility-an-interview-with-christian-kramme/</link>
          <title>Co-first author of the paper, Christian Kramme, at his bench at the Wyss Institute. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/09/23104321/STAMPScreen-Christian-Kramme-posed-1135.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3733c7491501107b63e8c96612448bd3"/></url>
				</image>
        			</item>

		
			<item>
				<title>A major step forward for organ biofabrication</title>
				<link>https://wyss.stage.a17.io/news/a-major-step-forward-for-organ-biofabrication/</link>
        <pubDate>Wed, 13 Jul 2022 14:00:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Biomechanics]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Stem Cells]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=33163</guid>
                            <description>By recreating the helical structure of heart muscles, researchers improve understanding of how the heart beats</description>
                                        <content:encoded><![CDATA[<p>By Leah Burrows / SEAS Communications (CAMBRIDGE, Mass.) ‑ Heart disease &mdash; the leading cause of death in the U.S. &mdash; is so deadly in part because the heart, unlike other organs, cannot repair itself after injury. That is why tissue engineering, ultimately including the wholesale fabrication of an entire human heart for transplant, is so important for the future of cardiac medicine.</p>
<p><a href="https://wyss.stage.a17.io/news/a-major-step-forward-for-organ-biofabrication/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/a-major-step-forward-for-organ-biofabrication/</link>
          <title>This image shows a biohybrid model of a four-chambered heart engineered with Focused Rotary Jet Spinning (FRJS) technology and recapitulating the helical tissue alignment of the human heart. Credit: Harvard SEAS</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/07/11141453/FXJ7cQoWIAEH0Rm.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=4ef11f0877ba0881e38672d9726caca1"/></url>
				</image>
        			</item>

		
			<item>
				<title>Getting to the heart of engineering a heart</title>
				<link>https://wyss.stage.a17.io/news/getting-to-the-heart-of-engineering-a-heart/</link>
        <pubDate>Wed, 08 Jun 2022 14:58:05 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Artificial Heart]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[Tissue Regeneration]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=32731</guid>
                            <description>New tissue engineering capabilities enable researchers to program contractility in functional layers of heart tissue bioprinted with human stem cell-derived organ building blocks</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Heart disease is the leading cause of death among adults and infants in the U.S. with about 659,000 people dying from heart disease each year, every one in four deaths. Among the many patients with a critical heart condition, about 3,500 are waiting for a heart transplant. Many of them will wait for more than six months, and for some of them time will run out&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/getting-to-the-heart-of-engineering-a-heart/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/getting-to-the-heart-of-engineering-a-heart/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/06/07165215/3D-Bioprinting-of-complex-heart-muscle-layer-geometries-listing-image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7ecb258af19d73fe0422c95f8a7b0b0e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Programming complex tissue organizations in 3D</title>
				<link>https://wyss.stage.a17.io/news/programming-complex-tissue-organizations-in-3d/</link>
        <pubDate>Tue, 10 May 2022 12:58:35 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Bioinspired Engineering]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Neuroscience]]></category>
		<category><![CDATA[Stem Cells]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=32477</guid>
                            <description>Simultaneous, programmable generation and organization of cell types with different origins and functions in artificial tissues could invigorate future biomedical 3D organ and tissue engineering</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Tissue engineers have developed a variety of approaches to recreate organs and tissues de novo outside the human body for use in regenerative therapies, drug screening, and disease modeling. As two prominent examples, human &ldquo;organoids&rdquo; are being assembled from cells to form tiny artificial constructs in a dish that resemble human organs and larger human tissues&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/programming-complex-tissue-organizations-in-3d/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/programming-complex-tissue-organizations-in-3d/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/05/07134925/Bioprinting_organioids-Fig-5H_top_right-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cd48658f352d0103e96b10268d1e3c82"/></url>
				</image>
        			</item>

		
			<item>
				<title>Harvard University licenses kidney engineering technology to Trestle Biotherapeutics to facilitate new kidney replacement therapies</title>
				<link>https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/</link>
        <pubDate>Tue, 22 Feb 2022 18:57:14 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=31690</guid>
                            <description>Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON/CAMBRIDGE, Mass.) &mdash; A newly launched startup is building upon innovations developed over several years at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering &amp; Applied Sciences (SEAS), and Brigham and Women&rsquo;s Hospital (Brigham) to engineer functional kidney tissue for renal repair and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/</link>
          <title>JThis image shows a kidney organoid (blue) embedded with vascular channels (red). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/02/18130445/Vascularized-kidney-organoid-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f56937666af30e9e5d9f497a9e778161"/></url>
				</image>
        			</item>

			</channel>
</rss>
